We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

29 hedge funds and large institutions have $3.9M invested in Microbot Medical in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 2

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

4% more funds holding

Funds holding: 28 → 29 (+1)

2.41% less ownership

Funds ownership: 12.19% → 9.78% (-2.4%)

40% less capital invested

Capital invested by funds: $6.54M → $3.9M (-$2.65M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
10
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.59M
2
BlackRock
BlackRock
New York
+$258K
3
Citadel Advisors
Citadel Advisors
Florida
+$162K
4
Morgan Stanley
Morgan Stanley
New York
+$126K
5
Northern Trust
Northern Trust
Illinois
+$112K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$773K
2
Renaissance Technologies
Renaissance Technologies
New York
-$647K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$135K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$58.1K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$41
Name Holding Trade Value Shares
Change 		Change in
Stake
WT
26
Washington Trust
Rhode Island
– +$9 +1 New
BCM
27
Bourgeon Capital Management
Connecticut
– +$96 +11 New
PFO
28
Pathstone Family Office
New Jersey
– +$219 +25 New
PFGIA
29
Patriot Financial Group Insurance Agency
Massachusetts
– +$701 +80 New
1
2

MBOT Hedge Fund Activity: Q1 2020 in Review

29 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2020, worth a combined $3.9M — down 40% from $6.54M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MBOT positions and 7 closed out — a net gain of 4 holders — while 10 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.59M. The largest seller was Sabby Management, exiting entirely with an estimated $773K sold.

  • 29 institutional investors held Microbot Medical (MBOT) as of Q1 2020, up from 28 in Q4 2019.
  • Funds reported $3.9M of Microbot Medical stock for Q1 2020, down 40% quarter-over-quarter.
  • 11 funds opened new Microbot Medical positions in Q1 2020 and 7 closed out, a net change of +4 holders.
  • The largest Microbot Medical buyer in Q1 2020 was Vanguard Group, an estimated $1.59M added.
  • The largest Microbot Medical seller in Q1 2020 was Sabby Management, an estimated $773K sold.

Based on aggregated 13F filings for Q1 2020.